Brainstorm Cell shareholders OK 150M authorized share increase, reverse split, equity plan boost

BRAINSTORM CELL THERAPEUTICS INC.

Stockholders approved increasing authorized common shares from 100M to 250M.
Board authorized to effect reverse stock split of 1:5 to 1:15 at any time before Sept 16, 2025.
Equity plan share pool increased by 8M shares to 13.6M; each plan extended to 2034.
All seven director nominees elected; Brightman Almagor Zohar & Co. ratified as auditor.
Advisory vote on executive compensation approved with a 3-year frequency for future votes.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.